Skip to main content

Table 1 Summary of coagulation problems plus the levels of coagulation parameters and inflammatory markers in patients with COVID-19

From: Major coagulation disorders and parameters in COVID-19 patients

Group

Name

Abbreviation

Dominant changes

References

Coagulation problems

Arterial thromboembolism

ATE

Blood clotting

[26,27,28,29,30,31]

 

Deep vein thrombosis

DVT

Blood clotting

[20,21,22,23,24,25]

 

Disseminated intravascular coagulation/sepsis-induced coagulopathy

DIC/SIC

Blood clotting

[26, 32,33,34,35,36,37,38,39,40]

 

Pulmonary embolism

PE

Blood clotting

[7,8,9,10,11]

 

Venous thromboembolism

VTE

Blood clotting

[12,13,14,15,16,17,18,19]

Coagulation parameters

D-dimer

Increase

[57, 67,68,69,70]

 

Factor VIII/Von Willebrand factor

FVIII/VWF

Increase

[71,72,73,74,75,76,77]

 

Fibrinogen and Fibrin degradation products

FDP

Increase

[57,58,59,60,61,62,63,64,65,66]

 

Lymphocyte count

Decrease

[41,42,43,44,45,46]

 

Partial thromboplastin time/Prothrombin time

PTT/PT

Get longer

[64, 78,79,80,81,82,83,84,85]

 

Platelet count

Decrease

[47,48,49,50,51,52]

Inflammatory markers

Antiphospholipid antibodies

aPL antibodies

Increase

[102,103,104,105]

 

C-reactive protein/procalcitonin

CRP/PCT

Increase

[31, 88,89,90,91,92,93,94,95]

 

Lactate dehydrogenase

LDH

Increase

[96,97,98,99,100,101]

 

Neutrophil-to-lymphocyte ratio

NLR

Increase

[65, 66, 86, 87]